Bio Protocol (@bioprotocol): A more capital-efficient model for biotech is emerging
Estimated coin impact
Scores are not price-change percentages. High impact means a score of +70 or more, or -70 or less.
Impact unavailable
A more capital-efficient model for biotech is emerging DeSci agents + DeFi automation will not only lower the overhead costs of biotech by streamlining scientific funding, coordination and commercialization It will change the incentive model - giving patient groups the power to… x.com/nih/status/188… Quote [@NIH](https://www.twitter.com/NIH/status/1888004759396958263) > Last year, $9B of the $35B that the National Institutes of Health (NIH) granted for research was used for administrative overhead, what is known as “indirect costs.” Today, NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%, above…